Skip to content

Clinical trials

Observational Lung Neoplasms trials in Austria

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Neoplasms Phase: Observational Country / region: Austria Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20032
20101
20111
20121
20142
20161
20172
20202
20211
20221
20253

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Recruiting5
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amgen2
Arbeitsgemeinschaft medikamentoese Tumortherapie2
AstraZeneca2
Medical University of Vienna2
Bristol-Myers Squibb1
Hoffmann-La Roche1
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest1
Karl Landsteiner Institute for Lung Research and Pneumological Oncology1
Martin-Luther-Universität Halle-Wittenberg1
Sandoz1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Neoplasms17
Breast Neoplasms6
Ovarian Neoplasms5
Colorectal Neoplasms4
Urinary Bladder Neoplasms4
Carcinoma, Non-Small-Cell Lung3
Carcinoma, Hepatocellular2
Endocrine Gland Neoplasms2
Endometrial Neoplasms2
Esophageal Neoplasms2

Trials

Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.